This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Irena Lanc: Innovator in Multiple Myeloma Genomics
Introduction: Irena Lanc is a prominent inventor based in St. Louis, MO (US), known for her significant contributions to the field of genomics, particularly in the study of multiple myeloma. With a focus on personalized medicine, her work aims to improve treatment strategies for patients suffering from this complex disease.
Latest Patents: Irena Lanc holds a patent for an innovative method titled "Automated exposition of known and novel multiple myeloma genomic variants using a single sequencing platform." This patent describes a sequencing capture array designed to identify mutations in multiple myeloma. The technology enables targeted next-generation sequencing methods to detect single nucleotide variants (SNV), copy number variations (CNV), and translocation mutations in tumor cells. The capture array focuses on fewer than 500 genes associated with multiple myeloma, facilitating the analysis of tumor mutations and the development of personalized treatment plans for patients. The analytical methods presented in her patent allow for tumor mutations to be elucidated with coverage at a sequencing depth of no more than 500×, or as low as 100×, achieving optimal efficiency at around 300×.
Career Highlights: Irena Lanc is affiliated with Washington University, where she continues to advance her research in genomics and cancer treatment. Her work has garnered attention for its potential to revolutionize how multiple myeloma is diagnosed and treated.
Collaborations: Irena collaborates with esteemed colleagues, including Daniel Auclair and Michael H Tomasson, to further enhance the impact of her research in the field of multiple myeloma.
Conclusion: Irena Lanc's innovative contributions to the understanding and treatment of multiple myeloma exemplify the critical role of inventors in advancing medical science. Her work not only highlights the importance of genomics in personalized medicine but also paves the way for improved patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile